June 2025 FDA Recall Omeprazole by Dr. Reddy's Laboratories, Inc.
D-0525-2025 - Presence of foreign tablets/capsules

This Class II drug recall was voluntarily initiated by Dr. Reddy's Laboratories, Inc. on June 30, 2025 for the product Omeprazole. The FDA reported the reason for recall as presence of foreign tablets/capsules. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0525-2025

Reason for Recall
Presence of foreign tablets/capsules: presence of foreign Divalproex Sodium Extended-Release 250mg tablet in a bottle of omeprazole capsules.
Initiated
06-30-2025
Reported
07-23-2025
Quantity
1476 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Dr. Reddy's Laboratories, Inc.
Omeprazole Delayed-release Capsules, USP, 20mg, 1000-count bottle, Rx Only, Manufactured by: Dr. Reddy's Laboratories Limited, Bachupally - 500 090 INDIA, Manufactured for: Qualient Pharmaceuticals Health LLC, Grand Cayman, Cayman Islands, NDC 82009-022-10. NDC 82009-022-10

Batch or Lot Expiration Information

Lot# Lot: C2403017, Exp 12/31/2026

Affected Packages Involved in this Recall